MBX Biosciences Files for 8.5M Share IPO at $14-$16/sh
MBX Biosciences (MBX) has filed for 8,500,000 share IPO at $14-$16 per share.
J.P. Morgan, Jefferies, Stifel and Guggenheim Securities will serve as underwriters.
Source: Investing.com
Последние публикации
UniCredit CEO Orcel attended virtual meeting with Commerzbank, source says
28.09.2024 - 17:00
Online sellers on Walmart's Flipkart sue India watchdog over antitrust probe
28.09.2024 - 16:00
If your AI seems smarter, it's thanks to smarter human trainers
28.09.2024 - 15:00
Thyssenkrupp steel head prepares staff for 'tough' cuts
28.09.2024 - 15:00
Why gene therapy for sickle cell is slow to catch on with patients
28.09.2024 - 15:00
Here's how Morgan Stanley expects the US election to impact textile retailers
28.09.2024 - 13:00
How to prepare your portfolio for Q4
28.09.2024 - 12:00
Why Wells Fargo says investors have key decisions to make amid Fed easing cycle
28.09.2024 - 11:00
Nuclear power renaissance on the way: UBS
28.09.2024 - 11:00
Investing.com's stocks of the week
28.09.2024 - 11:00
Apple drops out of talks to join OpenAI investment round, WSJ reports
28.09.2024 - 09:00
US southeast faces daunting task cleaning up from Helene; death toll rises
28.09.2024 - 09:00
TD Bank nears possible guilty plea in money laundering probe, WSJ reports
28.09.2024 - 08:00
Boeing wage talks break off without progress to end strike, union says
28.09.2024 - 08:00
Apple drops out of talks to join OpenAI investment round, WSJ says
28.09.2024 - 06:00
